Back
Sportradar Group AG Vs. PTC Therapeutics Industry Stock Comparison
Buy
78
SRAD
Sportradar Group AG
Last Price:
10.93
Seasonality Move:
15.09%
Buy
75
PTCT
PTC Therapeutics
Last Price:
40.09
Seasonality Move:
23.62%
Buy
78
Sportradar Group AG (SRAD)
is a Buy
Is Sportradar Group AG a Buy, Sell or Hold?
- The current Sportradar Group AG [SRAD] share price is $10.94. The Score for SRAD is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- SRAD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $40.12. The Score for PTCT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRAD Stock Price Chart
What is Sportradar Group AG's stock price today?
-
The Sportradar Group AG share price today is $10.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRAD is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $40.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 70.27 | Buy |
Chaikin Money Flow: | 451500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.22 - 10.18) | Buy |
Bollinger Bands (100): | (9.7 - 11.16) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.88 | Buy |
Relative Strength Index (14 RSI): | 75.48 | Buy |
Chaikin Money Flow: | 1813835 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.43 - 34.31) | Buy |
Bollinger Bands (100): | (25.83 - 31.27) | Buy |
SRAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.03 | Buy |
20-day SMA: | 9.66 | Buy |
50-day SMA: | 10.35 | Buy |
200-day SMA: | 10.43 | Buy |
8-day EMA: | 10.23 | Buy |
20-day EMA: | 9.97 | Buy |
50-day EMA: | 10.13 | Buy |
200-day EMA: | 10.6 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.39 | Buy |
20-day SMA: | 31.64 | Buy |
50-day SMA: | 29.52 | Buy |
200-day SMA: | 28.16 | Buy |
8-day EMA: | 34.27 | Buy |
20-day EMA: | 32.1 | Buy |
50-day EMA: | 30.09 | Buy |
200-day EMA: | 30.46 | Buy |
Sportradar Group AG Earnings Growth & SRAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.14 per share, and an increase next year of $0.21 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.31 per share, a decrease this year of $0.10 per share, and an increase next year of $2.67 per share.
Sportradar Group AG Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |